Gross Margin

Swedish rugged tech firm JLT Mobile Computers posts grim financials, citing AI-driven costs. But a deeper look reveals a strategic pivot to new markets.

Reed's Q2 results show major operational gains and a shrinking net loss, but a steep sales decline and a looming cash crunch raise critical questions.

A pivotal ATF ruling reclassifies the BolaWrap as a restraint tool, not a weapon. This opens a vast private market, but as the tool expands beyond police, new questions of oversight arise.

MySize Inc. is consolidating its shares to stay on Nasdaq. We go beyond the press release to analyze if this financial maneuver is a path to stability or a warning sign.

As Semtech prepares its Q2 earnings call, all eyes are on its performance in AI data centers and IoT. Will the results validate the market's bullish outlook?

After a history of losses, Syra Health posts a second profitable quarter. We analyze the tech-driven strategy and key contracts fueling its turnaround.

A new junk removal franchise, JunkStart, is ditching volume for weight. Its first Omaha launch, led by a franchise veteran, signals a calculated assault on industry giants.

Draganfly posts 26% revenue growth and secures major defense contracts, but a widening comprehensive loss reveals the high cost of its aggressive expansion strategy.

Shimmick Corp. posts improving financials and a record backlog, but a closer look reveals the high cost of its strategic pivot from troubled legacy projects.

Tactile Medical's impressive Q2 profit growth is tempered by a product launch stumble, testing its execution as it places big bets on new markets and tech.

Fluent's Q2 results reveal a dramatic pivot, with Commerce Media Solutions booming 90%. But can this growth and a new in-store bet outrun a stark 'going concern' warning?

Revenue missed and its stock plunged, but Quanterix is betting on a new C-suite and its Alzheimer's test to navigate market headwinds and deliver on its promise.

Despite a slight revenue dip, Ultralife Corp. tripled its earnings per share. A look at how operational discipline and a record order book are charting its course.

Amidst declining North American sales, Under Armour is cutting products and chasing a premium identity. But can cost cuts and tariff refunds fuel a real comeback?

Interface posted stellar Q2 results, but a one-time $15.6M tariff refund inflated the numbers. The real story is the operational resilience of its strategy.

DouYu names a new CEO after the former chief's 'personal' exit, but a history of arrests and regulatory probes tells a deeper story of strategic survival.

Clarus Corp. stunned with a Q2 profit, but a $6.1M tariff refund clouds the picture. As one segment soars and another sinks, a strategic review looms.

Karat Packaging's profits surged 168% thanks to a massive one-time tariff refund. A deep dive reveals the real story lies in its strategic growth.

Resmed posts record revenue and boosts shareholder returns, but its strategic pivot and operational hurdles reveal a more complex story of medtech leadership.

Beyond the mixed GAAP results, ICU Medical’s strong non-GAAP growth and raised guidance reveal a company thriving after a strategic pivot.